Quality begins before the first patient enrolls.
At PhaseWell, quality is built into every stage of the study lifecycle, from the decisions made before a study begins to the execution that follows.
A commitment should mean something.
Many study challenges can be traced back to commitments that were never realistic to begin with. Overestimated patient availability. Aggressive enrollment projections. Studies accepted without the necessary expertise.
At PhaseWell, quality starts with making the right commitments. Before a study is accepted, investigators and operational leaders evaluate scientific fit, patient access, site readiness, and execution requirements.
We believe saying no to the wrong study is just as important as saying yes to the right one.
Feasibility informed by investigators who understand the disease, the protocol, and the realities of patient care.
Projections built on actual patient access, referral patterns, and site capacity. Reliable execution begins with realistic expectations.
The foundation of every sound decision.
Having high-quality data in clinical studies is critical because it forms the foundation for making sound, evidence-based decisions about whether a therapy is safe and effective.
Reliable data across all sites helps to ensure that study results are accurate, reproducible, and meaningful, strengthening the scientific integrity of the trial and building trust with regulators, healthcare providers, and patients.
One quality standard and shared operational practices across every PhaseWell site, so data is collected and managed the same way regardless of location.
~15% of the PhaseWell workforce is dedicated to Quality.
Experienced investigators who understand the science evaluate every protocol, conduct informed consent personally, and stay accountable for study execution. That judgment is what keeps data clean.
Network-wide. Every site. Every inspection.
Ready to evaluate PhaseWell for your next study?
Tell us about your protocol. We'll give you an honest assessment of fit.